
Immunotherapy in Glioblastoma: An Overview of Current Status
Introduction Glioblastoma (GB) is a prevalent primary malignant brain tumor in the United States (US) with an average annual age-adjusted incidence of 3.19 per 100,000 persons.1–3 Over 10,000 individuals in the US succumb to GB each year.4,5 The estimated …